News

Opexa Therapeutics announced that it has been named one of the “Top Projects to Watch” for the third consecutive year. A panel of independent experts recognized the biopharmaceutical company for its work in the development of personalized immunotherapies for autoimmune disorders, such as multiple sclerosis (MS) and neuromyelitis optica (NMO). Opexa was…

The Multiple Sclerosis Society (MS Society) in the U.K. recently announced  awards targeted towards new MS research. In total, 16 projects carefully selected by both a panel of experts and patients living with MS will share MS Society 2015 funding grants amounting to £1,979,879. All projects fulfilled the requirements of high scientific…

Findings from two studies, recently published in the Journal of Clinical Investigation, indicate that high levels of salt alter the stability of the immune system and make it more susceptible to inflammation. The studies, which were led by Dr. David Hafler from Yale University and Dr. Dominik…

Several studies have shown that exercise can improve movement in multiple sclerosis (MS), but new research indicates that it specifically may also  improve reaction time, a measurement of cognitive impairment. The study, titled “Acute effects of varying intensities of treadmill walking exercise on inhibitory control in persons with…

The United Kingdom based Multiple Sclerosis Society (MS Society) recently announced £1.98 million in grants to new MS research projects in different disease-related areas. A panel of experts carefully selected 16 projects to be funded through the MS Society’s 2015 grant round, totaling £1,979,879. All selected projects fulfill the requirements of…

In a new study, researchers have revealed the previously unknown function of the FAM126A gene in supporting myelination (the formation of the myelin sheath that protects neurons), a critically important process in the development and recovery of acute exacerbations in multiple sclerosis (MS). The research paper, entitled “The leukodystrophy protein…

The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in new MS research. After an in-depth, rigorous review process of the 58 applications submitted, 16 projects were awarded funding through the MS Society’s 2015 grant round totaling £1,979,879. All applications…

A research team from Oxford Brookes University is being given a £70,000 ($107,000) grant to analyze whether dark chocolate can help ease symptoms of multiple sclerosis (MS). The Multiple Sclerosis Society (MS Society) will fund the study. The goal of the project, according to a press release, is to investigate if a…

The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in new MS research. The 16 projects awarded funding through the MS Society’s 2015 grant round were thoroughly evaluated in a rigorous review process. In total, 58 projects applied for MS Society…

In a recent study entitled “Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice,” a team of researchers investigated whether interleukin (IL)-32, a cytokine with an established role in rheumatoid arthritis, has a protective function in a mouse model of human multiple…

A new report, written jointly by the NHiS Commissioning Excellence and the Multiple Sclerosis (MS) Trust, highlights the healthcare costs of emergency hospitalization of MS patients in the United Kingdom and points to more cost-effective and better ways to care for this patient population. The executive summary and full report are…

ForuMS is a new interactive and online “journal club” where clinicians treating multiple sclerosis (MS) patients or involved in research can discuss and analyze recent papers from top peer-reviewed journals covering the latest advances in disease diagnosis and management. The educational platform, sponsored by grants from Genzyme, Mallinckrodt Pharmaceuticals, and Medtronic, uses…

Sanofi, a global healthcare leader, and the Institut Pasteur, an internationally renowned center for biomedical research, recently honored four researchers with the Sanofi – Institut Pasteur Awards 2015 for their work in the fields of immunology and tropical and neglected diseases. One of the awardees, laureate in the Senior…

In a new study entitled “Reduced cortical microvascular oxygenation in multiple sclerosis: a blinded, case-controlled study using a novel quantitative near-infrared spectroscopy method,” a team of researchers at the Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary investigated whether frequency domain near-infrared spectroscopy technology can measure the potential…

Mitsubishi Motors North America, Inc. (MMNA) recently announced a nationwide auction of its first Mitsubishi Lancer Evolution Final Edition to raise money for the National Multiple Sclerosis Society. The auction is currently ongoing on eBay  and bidding will conclude on Nov. 21 at the 29th annual MS Dinner Auction, sponsored…

In a recent study entitled “Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination,” researchers investigated whether sulfasalazine treatment, an anti-inflammatory and immune-modulating drug, could promote remyelination of axons in an organism model of demyelination diseases such as multiple sclerosis (MS). The study was published in the…

A new partnership between ARM and HeartToHeart Networks LLC has brought healthcare providers of patients with neurodegenerative disorders, such as multiple sclerosis, a new and secure tool for remote health management. The novel health management (RHM) solution combines technology from both companies. It uses mobile devices adapted with a Trusted…

A major new report published by the U.K. MS Trust has determined that the country’s National Health Services (NHS) programs relied on by people living with multiple sclerosis (MS) are facing increasing pressures that could lead to inequities in care. Evidence from the Letchworth Garden City, Hertfordshire based MS Trust’s…

In a new study entitled “Untargeted plasma metabolomics identifies endogenous metabolite with drug-like properties in chronic animal model of multiple sclerosis,” a team of researchers performed a comparative analysis of metabolites between control mice and a mouse model with experimental autoimmune encephalitis (EAE, the most commonly used…

Roche recently provided an update on their late-stage pipeline products across several therapeutic areas, including ocrelizumab for the treatment of multiple sclerosis. The data was disclosed on Nov. 5 at the Roche Pharma Day 2015 event in London, U.K. Ocrelizumab was previously revealed to be the first investigational medicine…

MyTomorrows, a company that provides information and facilitates requests regarding clinical trials, diagnostic tests and medicines through its internet-based platform, and Hemispherx Biopharma, Inc, a pharmaceutical company specialized in the development of new therapies for life-threatening disorders, have partnered in an effort to make Hemispherx’s natural alpha interferon therapy…

In a recent study entitled “Myeloid cells as target of fingolimod action in multiple sclerosis,” a team of scientists investigated the impact of fingolimod (Gilenya, Novartis), an approved drug for multiple sclerosis (MS), on the reactivity of myeloid cells, a key group that comprises several immune cells that…

Two upcoming, free events for members of the multiple sclerosis community are to be held during the next few weeks at Coral Gables, Florida, and San Antonio, Texas, respectively. Sponsored by the pharmaceutical firm Genzyme, these interactive events will provide opportunities for people with MS and members of the MS community…

The National Multiple Sclerosis Society has dedicated over $21 million to fund 78 new multiple sclerosis (MS) research studies as part of a broad research plan designed to address MS, re-establish  lost functioning caused by the disease in patients, and ultimately end the disease forever. This recent round of investment into MS research is…

Fitbit, a company dedicated to the development of health and fitness products and experiences to help individuals adopt healthier lifestyles, recently announced the FitForGood initiative, a step challenge encouraging Fitbit fans to get fit for a good cause — with their steps translating into funding for three national non-profit organizations:…

A smartphone platform may eventually enable large-scale studies of patients with multiple sclerosis (MS) or other neurologic diseases, according to the findings of a recent study published in the journal Neurology, Neuroimmunology & Neuroinflammation. Smartphones, highly portable and popular, provide a significant opportunity to incorporate information across…

In a recent study entitled “MicroRNA expression profiling of human blood monocyte subsets highlights functional differences,” a team of researchers discovered a pool of 66 microRNAs that underlie differences in phenotype and function of a group of immune cells with key roles in multiple sclerosis. The study was published…

Findings from a recent study published in the Journal of Neurologic Physical Therapy showed that standard approaches to evaluating muscular strength and cardiorespiratory fitness among patients with multiple sclerosis (MS) might be underestimating the patients’ capacities, encouraging clinicians to prescribe less effective exercises. In the study entitled “…

In a recent study published in the journal Immunity, researchers at the Weizmann Institute of Science in Israel reported the findings that a small subtype of immune dendritic cells plays a role in the prevention of both metabolic syndrome and autoimmunity. The study is entitled “…

In a new study entitled “Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation,” a team of scientists discovered the mechanism by which autoreactive T cells are capable of penetrating a patient’s brain and induce multiple sclerosis. The study was recently published in the advance online issue…